Exane Derivatives’s Bloomin' Brands BLMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,821
Closed -$1.11M 813
2022
Q1
$1.11M Sell
50,821
-1,692
-3% -$36.5K 0.31% 75
2021
Q4
$1.1M Buy
+52,513
New +$1.11M 0.27% 76
2017
Q3
Sell
-1
Closed -$21 580
2017
Q2
$21 Hold
1
﹤0.01% 615
2017
Q1
$20 Hold
1
﹤0.01% 551
2016
Q4
$18 Hold
1
﹤0.01% 617
2016
Q3
$17 Hold
1
﹤0.01% 606
2016
Q2
$18 Hold
1
﹤0.01% 528
2016
Q1
$17 Buy
+1
New +$17 ﹤0.01% 576
2015
Q4
Sell
-1
Closed -$18 529
2015
Q3
$18 Hold
1
﹤0.01% 516
2015
Q2
$21 Hold
1
﹤0.01% 512
2015
Q1
$24 Hold
1
﹤0.01% 509
2014
Q4
$25 Buy
+1
New +$21 ﹤0.01% 511

Other funds holding BLMN

Exane Derivatives's BLMN Position: Q2 2022 in Review

Exane Derivatives sold out of Bloomin' Brands (BLMN) in Q2 2022, closing a stake of 50,821 shares — an estimated $1.11M sold.

Exane Derivatives first reported a position in BLMN in Q4 2014 and held it in 12 quarters. The position peaked at $1.11M in Q1 2022. 269 funds tracked by Wall St. Rank hold BLMN as of Q2 2022.

  • Exane Derivatives reported no remaining Bloomin' Brands position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 50,821 Bloomin' Brands shares in Q2 2022, an estimated $1.11M.
  • Exane Derivatives first reported a position in Bloomin' Brands in Q4 2014 and held it in 12 quarters.
  • Exane Derivatives's Bloomin' Brands position peaked at $1.11M in Q1 2022.
  • 269 funds tracked by Wall St. Rank held Bloomin' Brands as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.